Key features
Strong historical results, managed by an investment team with more than 45 years of experience
Seeks opportunities within technology, health care, and applied science and technology
Built on a six-decade firm legacy of technology investing expertise
Daily pricing
as of
05/26/2023
NAV 1-day net change
0.54
Total net assets
as of
04/30/2023
All share classes
$489.9 million
Overview
Series identifiers |
CUSIP |
46600H794 |
Benchmark
Portfolio
Market cap (median) Source: FactSet
$45.0 billion
Market cap (weighted average) Source: FactSet
$499.6 billion
Portfolio turnover (last fiscal year)
58%
International equities & depositary receipts
8.1%
Cash, cash equivalents and other assets
5.3%
Top 10 holdings
as of 04/30/2023
Holdings are as of the date indicated and subject to change.
List may exclude cash and cash equivalents. Please see the Series' complete list of holdings for more information.
Holdings based by issuer.
MICROSOFT CORPORATION
9.09
SEAGATE TECHNOLOGY UNLIMITED CO
3.98
Total % Portfolio in Top 10 holdings - 44.82%
Sector allocation
as of 04/30/2023
List may exclude cash, cash equivalents, and exchange-traded funds (ETFs) that are used for cash management purposes. Please see the Series’ complete list of holdings for more information.
Information technology
60.0%
Communication services
11.0%
Consumer discretionary
7.0%
Management
Gus C. Zinn, CFA
-
Managing Director, Senior Portfolio Manager
-
Start date on the Fund:
October 2001
-
Years of industry experience:
24
-
Read bio
Gus C. Zinn
Managing Director, Senior Portfolio Manager
Gus C. Zinn is a Senior Portfolio Manager for Ivy Investments, now part of Macquarie Asset
Management’s Delaware Management Company. He joined Macquarie Asset Management (MAM) as part of
the firm’s April 30, 2021 acquisition (Transaction) of the investment management business of Waddell & Reed
Financial, Inc., the parent company of Ivy Investment Management Company (IICO), the former investment
advisor of the Transaction Funds. He joined IICO in 1998 and had served as the portfolio manager for
investment companies managed by IICO (or its affiliates) since 2006. He had served as assistant portfolio
manager for funds managed by IICO since July 2003, in addition to his duties as a research analyst. He
earned a bachelor’s degree and a master’s degree in finance from the University of Wisconsin-Madison.
Bradley J. Warden, CFA
-
Managing Director, Senior Portfolio Manager
-
Start date on the Fund:
October 2016
-
Years of industry experience:
25
-
Read bio
Bradley J. Warden
Managing Director, Senior Portfolio Manager
Bradley J. Warden is a Senior Portfolio Manager for Ivy Investments, now part of Macquarie
Asset Management’s Delaware Management Company. He joined Macquarie Asset Management (MAM) as part
of the firm’s April 30, 2021 acquisition (Transaction) of the investment management business of Waddell & Reed
Financial, Inc., the parent company of Ivy Investment Management Company (IICO), the former investment
advisor of the Transaction Funds. He joined IICO in 2003 as an investment analyst and became an assistant
portfolio manager for investment companies managed by IICO (or its affiliates) in 2014. He took on portfolio
management responsibilities in 2016. He earned a bachelor's degree in business administration from Trinity
University and an MBA in finance from the University of Texas at Austin.
Fees
The following table describes the fees and expenses that you may pay if you buy, hold, and sell shares of the Series. The fee table does not reflect any fees or sales charges imposed by variable insurance contracts. If it did, the expenses would be higher.
Annual series operating expenses |
Management fees |
0.85% |
Distribution and service (12b-1) fees |
0.25% |
Other expenses |
0.07% |
Total annual Series operating expenses |
1.17% |
Fee waivers and expense reimbursements1 |
none |
Total annual series operating expenses after fee waivers and expense reimbursements |
1.17% |
Please see the prospectus and SAI for additional information.
1Net expense ratio reflects a contractual waiver of certain fees/and/or expense reimbursements from May 1, 2023 through April 30, 2024. Please see the fee table in the Series' prospectus for more information.